Molecular markers to identify patients at risk for recurrence after primary treatment for prostate cancer.
about
LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancerQuantitative analysis of a panel of gene expression in prostate cancer--with emphasis on NPY expression analysis.Polycyclic aromatic hydrocarbon--DNA adducts in prostate and biochemical recurrence after prostatectomyQuantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer.Differential proteomic alterations between localised and metastatic prostate cancer.Evaluation of a variant in the transcription factor 7-like 2 (TCF7L2) gene and prostate cancer risk in a population-based study.Correlation of MR imaging and MR spectroscopic imaging findings with Ki-67, phospho-Akt, and androgen receptor expression in prostate cancer.Measurement of blood E2F3 mRNA in prostate cancer by quantitative RT-PCR: a preliminary study.The elevated expression of a mismatch repair protein is a predictor for biochemical recurrence after radical prostatectomy.Prediction of prostate cancer recurrence using magnetic resonance imaging and molecular profiles.Imaging primary prostate cancer with 11C-Choline PET/CT: relation to tumour stage, Gleason score and biomarkers of biologic aggressiveness.The oncogenic transcription factor ERG represses the transcription of the tumour suppressor gene PTEN in prostate cancer cells.
P2860
Q21202034-8E3C547C-6D0D-4AF2-9FC5-98E54583CEDCQ33318669-04BA0FCC-5C37-43E2-8633-8FA9DD58EB96Q33641222-2442F0C5-9275-4BD0-995F-45C4309999D2Q33697764-3879745B-1F67-4961-865F-A541CA227D7AQ36553042-20B26E42-23D4-4B58-BBDB-912D9A239675Q37395071-86CFC538-E369-4A39-84EB-D31E5EC05A5BQ37401554-72CD3B9F-7801-45CF-9E36-AB7BE6F00BC2Q40093279-1CE54D10-35FA-4552-B97C-603F006287ADQ41829002-0BFABD68-33AC-44DB-9F7C-9D7D8A89BC13Q41831958-D6F172B9-009C-4AA7-9386-7D1CA5EABEBDQ42423216-412B4996-6E02-41AF-8D79-F29488EF01E8Q47102112-D28FABC2-89C4-4328-A3CB-686AAEB6C19B
P2860
Molecular markers to identify patients at risk for recurrence after primary treatment for prostate cancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Molecular markers to identify ...... treatment for prostate cancer.
@ast
Molecular markers to identify ...... treatment for prostate cancer.
@en
type
label
Molecular markers to identify ...... treatment for prostate cancer.
@ast
Molecular markers to identify ...... treatment for prostate cancer.
@en
prefLabel
Molecular markers to identify ...... treatment for prostate cancer.
@ast
Molecular markers to identify ...... treatment for prostate cancer.
@en
P1433
P1476
Molecular markers to identify ...... treatment for prostate cancer.
@en
P2093
Arul M Chinnaiyan
Chandan Kumar-Sinha
P356
10.1016/J.UROLOGY.2003.10.007
P407
P478
62 Suppl 1
P577
2003-12-01T00:00:00Z